✦ LIBER ✦

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

✍ Scribed by Tan, Meng H.; Glazer, N. Bradly; Johns, Don; Widel, Mario; Gilmore, Kathryn J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with pioglitazone pl

✍ Marc S. Rendell; N.Bradly Glazer; Zhan Ye 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Comparison of insulin monotherapy and co

✍ Hamiyet Yilmaz; Alptekin Gursoy; Mustafa Sahin; Nilgun Guvener Demirag 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 185 KB

Testing the Therapeutic Equivalence of A

✍ Messori, Andrea; Fadda, Valeria; Maratea, Dario; Trippoli, Sabrina; Marinai, Cla 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 372 KB

2-Year effects of pioglitazone add-on to

✍ Jochen Seufert; Richard Urquhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 429 KB

The long-term effect of pioglitazone as

✍ JohnW. Egan; Renee Librizzi; JamesS. Geerlof 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Loss of Glycemic Control in Patients wit

✍ Dr. Aylin A. Riedel; Mr. Herbert Heien; Ms. Jenifer Wogen; Dr. Craig A. Plauschi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB